90 related articles for article (PubMed ID: 6971934)
1. T lymphocyte colony formation and autoimmune disease: in vitro assessment of immunopathology.
Eckels DD; Gershwin ME
J Rheumatol; 1981; 8(2):214-9. PubMed ID: 6971934
[TBL] [Abstract][Full Text] [Related]
2. Cloning of T-lymphocytes in systemic lupus erythematosus.
Whittingham S; Rodger B; Matthews JV; Mackay IR
Clin Exp Immunol; 1978 Oct; 34(1):63-8. PubMed ID: 312168
[TBL] [Abstract][Full Text] [Related]
3. Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus.
Kumagai S; Sredni B; House S; Steinberg AD; Green I
J Immunol; 1982 Jan; 128(1):258-62. PubMed ID: 6976374
[TBL] [Abstract][Full Text] [Related]
4. [Effect of female sex hormones on blastic transformation of lymphocytes in systemic lupus erythematosus and in healthy women].
Pozsonyi T; Jakab L; Gonzalez-Cabello R; Cao VV; Cseh K; Kalabay L; Marticsek J; Gergely P; Jakab L
Orv Hetil; 1987 Dec; 128(51):2677-8, 2681-2. PubMed ID: 3324000
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of human T lymphocyte colony formation by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kitamura K; Urabe A; Ozawa K; Kimura Y; Takaku F
Exp Hematol; 1983 Nov; 11(10):1014-20. PubMed ID: 6607173
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
7. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus in a colony of dogs.
Monier JC; Fournel C; Lapras M; Dardenne M; Randle T; Fontaine CM
Am J Vet Res; 1988 Jan; 49(1):46-51. PubMed ID: 3258482
[TBL] [Abstract][Full Text] [Related]
9. Multipotent hemopoietic progenitor cells in patients with systemic lupus erythematosus.
Otsuka T; Okamura S; Harada M; Ohhara N; Hayashi S; Yamaga S; Nagasawa K; Niho Y
J Rheumatol; 1988 Jul; 15(7):1085-90. PubMed ID: 3262755
[TBL] [Abstract][Full Text] [Related]
10. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
11. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T
Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
[TBL] [Abstract][Full Text] [Related]
12. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
13. Impaired T-lymphocyte colony formation in lipoid nephrosis.
Matsumoto K; Okano K; Yoshizawa N; Harada M; Ohi H; Hatano M
Clin Nephrol; 1985 Dec; 24(6):279-84. PubMed ID: 3878248
[TBL] [Abstract][Full Text] [Related]
14. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
15. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
17. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subsets in systemic lupus erythematosus.
Cheong SK; Chin SF; Kong NC
Malays J Pathol; 1997 Dec; 19(2):121-5. PubMed ID: 10879252
[TBL] [Abstract][Full Text] [Related]
19. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
[TBL] [Abstract][Full Text] [Related]
20. Phytohemagglutinin or pokeweed mitogen induction of in vitro colony formation by T-cells from patients with chronic lymphocytic leukemia.
Pistoia V; Nocera A; Ghio R; Minale P; Ferrarini M
J Natl Cancer Inst; 1982 Feb; 68(2):233-7. PubMed ID: 6977670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
